Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.9K
1.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Cancer Therapies02:49

Cancer Therapies

10.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Outcomes for Patients who Received Both Trastuzumab Deruxtecan (T-DXd) and Trastuzumab Emtansine (T-DM1) for HER2-Mutant non-Small Cell Lung Cancer.

JTO clinical and research reports·2026
Same author

Inflammatory immune modulators of AML lung infiltration and respiratory failure.

Nature immunology·2026
Same author

LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer.

Cancer discovery·2026
Same author

Brain Metastases in Diffuse Pleural Mesothelioma: Clinical, Histologic, and Molecular Correlates.

JTO clinical and research reports·2026
Same author

ALK Inhibitor Response in Novel <i>ZFPM2::ALK</i> and <i>TRIM24::ALK</i> Fusion-Positive Lung Cancers: Case Report.

JTO clinical and research reports·2026
Same author

The integrated stress response promotes immune evasion through lipocalin 2.

Nature·2026

Related Experiment Video

Updated: Apr 20, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K

Personalized therapy for lung cancer.

Andre L Moreira1, Juliana Eng2

  • 1Department of Pathology, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY.

Chest
|December 3, 2014
PubMed
Summary

Advancements in lung cancer therapy, particularly adenocarcinoma, now utilize personalized medicine targeting specific mutations. Next-generation sequencing (NGS) enables comprehensive molecular profiling from small tissue samples, improving diagnosis and drug discovery.

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.6K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.6K

Related Experiment Videos

Last Updated: Apr 20, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.6K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.6K

Area of Science:

  • Oncology
  • Molecular Pathology
  • Genomics

Background:

  • Lung cancer therapy has advanced significantly, with personalized approaches targeting specific mutations, especially in adenocarcinoma.
  • The discovery of actionable mutations, like those in the epidermal growth factor receptor gene, has driven the development of targeted therapies.

Purpose of the Study:

  • To highlight the advancements in lung cancer therapy driven by molecular discoveries.
  • To emphasize the role of Next-Generation Sequencing (NGS) in modern lung cancer diagnostics and research.

Main Methods:

  • Review of therapeutic advancements and molecular target discoveries in lung cancer.
  • Description of Next-Generation Sequencing (NGS) technology for molecular pathology.

Main Results:

  • NGS allows for the simultaneous evaluation of multiple molecular alterations in a single tissue sample.
  • Targeted gene sequencing using NGS is suitable for clinical practice, conserving tissue for future studies.

Conclusions:

  • NGS is a crucial diagnostic tool for lung cancer, facilitating personalized medicine and new drug discovery.
  • The technology aids in understanding gene interactions, drug response, and resistance mechanisms in lung cancer.